Metformin with Temozolomide for Newly Diagnosed Glioblastoma: Results of Phase I Study and a Brief Review of Relevant Studies
Makoto Ohno(Tokyo National Hospital), Yoshitaka Narita(Unknown), Chifumi Kitanaka(Yamagata University), Yasuji Miyakita, Yukihiko Sonoda(Yamagata University), Kazuhiko Mishima, Motoo Nagane(Kyorin University), Masamichi Takahashi(Tokai University Hospital), Shota Tanaka(The University of Tokyo), Eiichi Ishikawa(Kyushu University), Ken Ohashi(University of Tsukuba), Shunsuke Yanagisawa(Tokyo University of Science)
Cited by 18
Related Papers
Caspase-independent programmed cell death with necrotic morphology
|Cell Death and Differentiation|1999|373
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
|Nature Communications|2019|372
Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells
|Oncogene|1999|251
Physical and Functional Interactions between Pim-1 Kinase and Cdc25A Phosphatase
|Journal of Biological Chemistry|1999|243